This event is archived. Final snapshot from when the story concluded. View on Dashboard
Events / VistaGen Therapeutics Faces...
Business shareholder lawsuit

VistaGen Therapeutics Faces Shareholder Lawsuit

Analysis based on 7 articles · First reported Feb 04, 2026 · Last updated Mar 12, 2026

Sentiment
-20
Attention
2
Articles
7
Market Impact
Direct
Live prominence charts, article sentiment distribution, and event development timeline available on the NewsDesk Dashboard
Market Impact

The market is likely to react negatively to VistaGen Therapeutics due to the class action lawsuit, potentially leading to a decrease in its stock price. This event highlights the importance of transparent communication from pharmaceutical companies regarding clinical trial results.

Biotechnology Pharmaceuticals
Event Summary

A shareholder class action lawsuit has been filed against VistaGen Therapeutics, Inc. The lawsuit alleges that VistaGen Therapeutics issued false and misleading statements and/or failed to disclose material adverse facts regarding the risks of failure associated with its Phase 3 PALISADE-3 trial study of fasedienol. Shareholders who purchased VistaGen Therapeutics shares between April 1, 2024, and December 16, 2025, and experienced significant losses are encouraged to seek legal counsel.

Key Actions
100 Corey D. Holzer filed a shareholder class action lawsuit VistaGen Therapeutics
90 VistaGen Therapeutics issued false and misleading statements
90 VistaGen Therapeutics failed to disclose material adverse facts
Entities Involved
stock
VistaGen Therapeutics
VistaGen Therapeutics is facing a shareholder class action lawsuit due to allegedly false and misleading statements regarding its Phase 3 PALISADE-3 trial of fasedienol. This could lead to significant financial penalties and reputational damage for VistaGen Therapeutics.
Importance 100 Sentiment -70
per
Corey D. Holzer
Corey D. Holzer, Esq. is encouraging VistaGen Therapeutics shareholders who experienced losses to discuss their legal rights, indicating his involvement in the class action lawsuit.
Importance 20 Sentiment 0
priv
Holzer & Holzer
Holzer & Holzer is the law firm representing the shareholders in the class action lawsuit against VistaGen Therapeutics.
Importance 20 Sentiment 0
Relationships
Corey D. Holzer related ↔ Holzer & Holzer
NEWSDESK
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.